Taneli Jouhikainen
2018
In 2018, Taneli Jouhikainen earned a total compensation of $3.9M as Chief Operating Officer & President at Mast Therapeutics, a 547% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $204,094 |
|---|---|
| Option Awards | $3,133,803 |
| Salary | $525,000 |
| Other | $22,000 |
| Total | $3,884,897 |
Jouhikainen received $3.1M in option awards, accounting for 81% of the total pay in 2018.
Jouhikainen also received $204.1K in non-equity incentive plan, $525K in salary and $22K in other compensation.
Rankings
In 2018, Taneli Jouhikainen's compensation ranked 2,882nd out of 14,244 executives tracked by ExecPay. In other words, Jouhikainen earned more than 79.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,882 out of 14,244 | 80th |
Division Manufacturing | 1,060 out of 5,765 | 82nd |
Major group Chemicals And Allied Products | 368 out of 2,128 | 83rd |
Industry group Drugs | 301 out of 1,817 | 83rd |
Industry Pharmaceutical Preparations | 229 out of 1,391 | 84th |
Pay ratio
| Taneli Jouhikainen's Pay | $3,884,897 |
|---|---|
| Median Employee's Pay | $282,179 |
| Pay Ratio | 14to 1 |
In 2018, the annual total compensation of Taneli Jouhikainen was $3,884,897.
The annual total compensation of the median employee at Mast Therapeutics was $282,179.
The ratio of Taneli Jouhikainen's pay to the pay of median employee was therefore 14 to one.
Source: SEC filing on April 15, 2019.
Jouhikainen's colleagues
We found three more compensation records of executives who worked with Taneli Jouhikainen at Mast Therapeutics in 2018.